2009 Emerging Growth Company Conference
| Monday, May 4, 2009 | Tuesday, May 5, 2009 |
| Mention AdvaMed for special room rates. Fairmont provides shuttle services to Edwards Lifesciences LLC | Edwards Lifesciences LLC |
AdvaMed's 9th Emerging Growth Company conference addresses issues of particular concern to CEO's and senior-level executives from manufacturers with sales less than $100 million. Gain insights from top business leaders and network with potential business partners.
Monday, May 4, 2009
| 3:30-5:30pm | Understanding the revised AdvaMed Code of Ethics and how can smaller companies implement an effective compliance program? | Andrew van Haute, Assistant General Counsel of AdvaMed; Michael Scarano, Partner Foley & Lardner |
| 5:30-7:00pm | Reception and Networking |
Tuesday, May 5, 2009
| Time | Topic | Presenters |
| 7:30-8:30am | Registration, Continental Breakfast and Networking | |
| 8:30-9:00am | Industry Outlook | Michael A. Mussallem, Chairman and CEO, Edwards Lifesciences LLC |
| 9:00-9:15am | Networking Break | |
| 9:15-10:00am | How should companies prepare themselves for an exit through an acquisition? Discussion on due diligence, valuation, enterprise risk management, human capital, partnership, etc. | John Babitt, Senior Manager and Life Science Sector Resident, Ernst & Young LLP; |
| 10:00-10:45am | Talk to the investors and learn where you might find sources of funding today. | Pete Shagory, Partner, Baird Venture Partners; |
| 10:45-11:15am | Networking Break | |
| 11:15-12:00pm | What is the best model for device development? | Introduction by Steve Halsey, InHealth and former Group Editor for MX Magazine, |
| 12:00-12:45pm | Tactical advice and guidance regarding regulatory and clinical trail considerations in current economy - opportunities to continue product development activities while avoiding significant capital expenditures. | Ron Warren, Principal Consultant, Medical Device Consultants, Inc and Michael Feldstein, Ph.D. and Principal Biostatistician |
| 12:45-1:45pm
| Lunch: In the Heart Valve Museum | |
| 1:45-2:30pm | What is the most effective approach with FDA | Janet Trunzo, Executive Vice President, Technology and Regulatory Dept., AdvaMed; Louis Mazzarese, Chief Regulatory Officer, Global Operations, Edwards Lifesciences |
Gold Sponsors | Silver Sponsors |
 |
|
Supporting Organizations
| |
.jpg){kind=logo}
Cancellation Policy
All cancellations must be in writing by April 24, 2009 to receive a Full refund. If you cancel after that date, you will receive a partial refund (your payment minus a $50 administrative fee).
Cancellations can be faxed or emailed to Roberta E. Speight at (202) 783-8750 or rspeight@advamed.org. Substitutions are acceptable by filing out a registration form and submitting to Roberta E. Speight.
